Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
AKTS Stock Summary
Top 10 Correlated ETFs
AKTS
In the News

Akoustis (AKTS) Reports Q1 Loss, Misses Revenue Estimates
Akoustis (AKTS) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.28 per share a year ago.

Akoustis Technologies, Inc. (AKTS) Q4 2023 Earnings Call Transcript
Akoustis Technologies, Inc. (NASDAQ:AKTS ) Q4 2023 Earnings Conference Call September 6, 2023 8:00 AM ET Company Participants Tom Sepenzis - Investor Relations Jeff Shealy - Founder & Chief Executive Officer Ken Boller - Chief Financial Officer Dave Aichele - EVP of Business Development Conference Call Participants Anthony Stoss - Craig-Hallum Craig Ellis - B. Riley Securities Suji Desilva - ROTH MKM Operator Good day, ladies and gentlemen, and welcome to the Akoustis Technologies Fiscal 2023 Fourth Quarter Conference Call.

Akoustis (AKTS) Reports Q4 Loss, Misses Revenue Estimates
Akoustis (AKTS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.26 per share a year ago.

Akoustis to Webcast Q4FY23 and Full Year Results on September 6 at 8:00 am ET
Charlotte, N.C., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, will webcast its fourth quarter and full year 2023 results on Wednesday, September 6, 2023, at 8:00 am Eastern Time. Management will host a question-and-answer session at the end of the call.

7 Tech Stocks to Buy to Turn $5,000 Into $1 Million
While converting $5,000 into a cool million would require a 200-bagger – a phenomenal return that's extremely difficult to actualize – if you're going to do it, the top tech stocks offer the most natural ecosystem. True, if the human lifespan expanded into centuries, going after agriculture plays might work.

Akoustis: Wi-Fi 6E Design Wins Continue To Drive Growth
Akoustis Technologies is disrupting the global RF-filter market with leading-edge materials science and its patented XBAW filter designs. Last week, Akoustis announced two more Wi-Fi 6E design wins one of which is ramping production now. The other customer will ramp-up in the 2H of this year. Both customers use multiple RF-filters in each end product.

Akoustis Technologies: Gains Rapid Traction
The company has a large and growing TAM and its patented XBAW technology is enjoying increasing market acceptance, witnessing multiple design wins. Production is ramping fast and costs have come down, operational cash flow will keep decreasing and could reach breakeven in four quarters. However, the company also has capex expansion plans, but it could get considerable help from the CHIPS Act here.

Akoustis (AKTS) Reports Q3 Loss, Lags Revenue Estimates
Akoustis (AKTS) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.22 per share a year ago.

Akoustis to Webcast Q3FY23 Results on May 8 at 8:00 am ET
Charlotte, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, will webcast its Q3FY23 results on Monday, May 8, 2023, at 8:00 am Eastern Time. Management will host a question-and-answer session at the end of the call.

Akoustis: I Hear Rapidly Growing Revenue From RF Disruption
Akoustis' proprietary XBAW RF Filter Technology is disrupting RF front-end designs from smartphones to PCs to home networking. As a result, Q2 FY2023 revenue was +59% yoy. That followed Q1 FY23 sales that grew 195% yoy.
AKTS Financial details
AKTS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.05 | 0.05 | 0.15 | 0.28 | 0.43 | |
Net income per share | -1.12 | -1.21 | -1.08 | -1.1 | -1 | |
Operating cash flow per share | -0.64 | -0.63 | -0.68 | -0.84 | -0.7 | |
Free cash flow per share | -0.82 | -0.93 | -0.96 | -1.35 | -0.88 | |
Cash per share | 1.1 | 1.31 | 2.03 | 1.49 | 0.68 | |
Book value per share | 0.94 | 1.23 | 2.7 | 1.91 | 1.36 | |
Tangible book value per share | 0.93 | 1.22 | 2.69 | 1.6 | 0.89 | |
Share holders equity per share | 0.94 | 1.23 | 2.7 | 1.91 | 1.36 | |
Interest debt per share | 0.56 | 0.57 | -0.11 | 0.83 | 0.75 | |
Market cap | 172.5M | 279.36M | 465.1M | 199.88M | 202.32M | |
Enterprise value | 160.56M | 258.97M | 377.25M | 164.25M | 204.64M | |
P/E ratio | -5.59 | -6.84 | -9.91 | -3.38 | -3.18 | |
Price to sales ratio | 119.54 | 156.07 | 70.28 | 13.02 | 7.46 | |
POCF ratio | -9.76 | -13.11 | -15.84 | -4.42 | -4.51 | |
PFCF ratio | -7.64 | -8.94 | -11.11 | -2.74 | -3.6 | |
P/B Ratio | 6.65 | 6.73 | 3.96 | 1.93 | 2.35 | |
PTB ratio | 6.65 | 6.73 | 3.96 | 1.93 | 2.35 | |
EV to sales | 111.27 | 144.68 | 57 | 10.7 | 7.55 | |
Enterprise value over EBITDA | -6.39 | -9.03 | -9.7 | -2.71 | -3.17 | |
EV to operating cash flow | -9.09 | -12.16 | -12.85 | -3.63 | -4.57 | |
EV to free cash flow | -7.11 | -8.29 | -9.01 | -2.25 | -3.64 | |
Earnings yield | -0.18 | -0.15 | -0.1 | -0.3 | -0.31 | |
Free cash flow yield | -0.13 | -0.11 | -0.09 | -0.36 | -0.28 | |
Debt to equity | 0.7 | 0.58 | 0 | 0.43 | 0.53 | |
Debt to assets | 0.38 | 0.33 | 0 | 0.28 | 0.31 | |
Net debt to EBITDA | 0.48 | 0.71 | 2.26 | 0.59 | -0.04 | |
Current ratio | 9.89 | 7.54 | 12.83 | 7.25 | 3.41 | |
Interest coverage | 9.53 | 7.01 | 8.07 | -786.43 | -28.45 | |
Income quality | 0.6 | 0.59 | 0.67 | 0.76 | 0.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 6.03 | 6.08 | 2.01 | 1.35 | 1.1 | |
Research and developement to revenue | 13.34 | 11.47 | 3.64 | 2.33 | 1.23 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0.11 | 0.2 | |
Capex to operating cash flow | 0.28 | 0.47 | 0.43 | 0.61 | 0.25 | |
Capex to revenue | -3.41 | -5.56 | -1.89 | -1.81 | -0.42 | |
Capex to depreciation | -1.97 | -3.12 | -2.56 | -3.41 | -0.98 | |
Stock based compensation to revenue | 5.02 | 3.76 | 1.24 | 0.67 | 0.35 | |
Graham number | 4.88 | 5.8 | 8.11 | 6.87 | 5.52 | |
ROIC | -0.66 | -0.55 | -0.37 | -0.39 | -0.48 | |
Return on tangible assets | -0.65 | -0.58 | -0.38 | -0.41 | -0.53 | |
Graham Net | 0.31 | 0.44 | 1.9 | 0.51 | -0.19 | |
Working capital | 28.61M | 40.07M | 85.93M | 79.07M | 42.27M | |
Tangible asset value | 25.57M | 40.95M | 116.84M | 86.39M | 56.44M | |
Net current asset value | 9.83M | 16.27M | 85.61M | 33.82M | -2.83M | |
Invested capital | 0.7 | 0.58 | 0 | 0.43 | 0.53 | |
Average receivables | 249.83K | 318K | 760.5K | 2.48M | 4.27M | |
Average payables | 192.08K | 1.19M | 1.66M | 2.41M | 3.8M | |
Average inventory | 75.78K | 115K | 763K | 2.74M | 5.82M | |
Days sales outstanding | 72.09 | 71.57 | 64.53 | 90.19 | 63.97 | |
Days payables outstanding | 88.28 | 322.81 | 40.71 | 67.99 | 48.03 | |
Days of inventory on hand | 33.87 | 20.56 | 47.63 | 76.68 | 91.11 | |
Receivables turnover | 5.06 | 5.1 | 5.66 | 4.05 | 5.71 | |
Payables turnover | 4.13 | 1.13 | 8.97 | 5.37 | 7.6 | |
Inventory turnover | 10.78 | 17.75 | 7.66 | 4.76 | 4.01 | |
ROE | -1.19 | -0.98 | -0.4 | -0.57 | -0.74 | |
Capex per share | -0.18 | -0.3 | -0.29 | -0.51 | -0.18 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q1
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.1 | 0.1 | 0.11 | 0.12 | 0.1 | |
Net income per share | -0.33 | -0.19 | -0.23 | -0.25 | -0.28 | |
Operating cash flow per share | -0.26 | -0.2 | -0.15 | -0.12 | -0.18 | |
Free cash flow per share | -0.35 | -0.25 | -0.18 | -0.14 | -0.24 | |
Cash per share | 1.06 | 0.81 | 0.77 | 0.6 | 0.36 | |
Book value per share | 1.52 | 1.37 | 1.47 | 1.2 | 0.94 | |
Tangible book value per share | 1.22 | 1.09 | 1.03 | 0.79 | 0.54 | |
Share holders equity per share | 1.52 | 1.37 | 1.47 | 1.2 | 0.94 | |
Interest debt per share | 0.77 | 0.76 | 0.66 | 0.64 | 0.6 | |
Market cap | 169.75M | 162.39M | 210.04M | 228.14M | 54.44M | |
Enterprise value | 153.98M | 160.1M | 202.83M | 230.46M | 72.45M | |
P/E ratio | -2.22 | -3.64 | -3.38 | -3.21 | -0.68 | |
Price to sales ratio | 30.5 | 27.69 | 28.55 | 27.38 | 7.77 | |
POCF ratio | -11.32 | -14.46 | -21.22 | -26.22 | -4.15 | |
PFCF ratio | -8.56 | -11.29 | -17.38 | -23.01 | -3.14 | |
P/B Ratio | 1.96 | 2.05 | 2.09 | 2.65 | 0.8 | |
PTB ratio | 1.96 | 2.05 | 2.09 | 2.65 | 0.8 | |
EV to sales | 27.66 | 27.3 | 27.57 | 27.66 | 10.35 | |
Enterprise value over EBITDA | -10.27 | -12.7 | -14.53 | -12.86 | -3.35 | |
EV to operating cash flow | -10.27 | -14.26 | -20.49 | -26.49 | -5.53 | |
EV to free cash flow | -7.77 | -11.13 | -16.78 | -23.24 | -4.18 | |
Earnings yield | -0.11 | -0.07 | -0.07 | -0.08 | -0.37 | |
Free cash flow yield | -0.12 | -0.09 | -0.06 | -0.04 | -0.32 | |
Debt to equity | 0.52 | 0.56 | 0.45 | 0.53 | 0.65 | |
Debt to assets | 0.31 | 0.33 | 0.29 | 0.31 | 0.34 | |
Net debt to EBITDA | 1.05 | 0.18 | 0.52 | -0.13 | -0.83 | |
Current ratio | 5.75 | 6.87 | 5.78 | 3.41 | 2.43 | |
Interest coverage | 24.18 | 18.36 | 33.89 | -48.85 | 44.65 | |
Income quality | 0.79 | 1.01 | 0.64 | 0.49 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.25 | 1 | 1.2 | 0.97 | 1.46 | |
Research and developement to revenue | 1.81 | 1.3 | 1 | 0.98 | 1.48 | |
Intangibles to total assets | 0.12 | 0.12 | 0.19 | 0.2 | 0.23 | |
Capex to operating cash flow | 0.32 | 0.28 | 0.22 | 0.14 | 0.32 | |
Capex to revenue | -0.87 | -0.54 | -0.3 | -0.15 | -0.6 | |
Capex to depreciation | -1.9 | -1.16 | -0.68 | -0.38 | -1.34 | |
Stock based compensation to revenue | 0.42 | 0.32 | 0.44 | 0.23 | 0.27 | |
Graham number | 3.38 | 2.45 | 2.75 | 2.59 | 2.42 | |
ROIC | -0.14 | -0.1 | -0.1 | -0.13 | -0.19 | |
Return on tangible assets | -0.15 | -0.1 | -0.12 | -0.15 | -0.21 | |
Graham Net | 0.13 | -0.02 | 0.04 | -0.17 | -0.38 | |
Working capital | 60.04M | 51.54M | 56.41M | 42.27M | 22.69M | |
Tangible asset value | 70M | 62.76M | 70.04M | 56.44M | 38.7M | |
Net current asset value | 14.71M | 7.13M | 11.17M | -2.83M | -20.77M | |
Invested capital | 0.52 | 0.56 | 0.45 | 0.53 | 0.65 | |
Average receivables | 3.38M | 3.07M | 3.71M | 4.5M | 4.35M | |
Average payables | 3.89M | 3.38M | 2.86M | 3.55M | 5M | |
Average inventory | 4.31M | 5.17M | 6.68M | 7.55M | 6.87M | |
Days sales outstanding | 48.12 | 48.66 | 51.96 | 51.33 | 50.67 | |
Days payables outstanding | 57.98 | 44.4 | 33.2 | 35.68 | 67.04 | |
Days of inventory on hand | 63.11 | 99.1 | 80.29 | 67.68 | 68.81 | |
Receivables turnover | 1.87 | 1.85 | 1.73 | 1.75 | 1.78 | |
Payables turnover | 1.55 | 2.03 | 2.71 | 2.52 | 1.34 | |
Inventory turnover | 1.43 | 0.91 | 1.12 | 1.33 | 1.31 | |
ROE | -0.22 | -0.14 | -0.15 | -0.21 | -0.3 | |
Capex per share | -0.08 | -0.05 | -0.03 | -0.02 | -0.06 |
AKTS Frequently Asked Questions
What is Akoustis Technologies, Inc. stock symbol ?
Akoustis Technologies, Inc. is a US stock , located in Huntersville of Nc and trading under the symbol AKTS
Is Akoustis Technologies, Inc. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $7. The lowest prediction is $7 and the highest is $7
What is AKTS stock prediction ?
What is Akoustis Technologies, Inc. stock quote today ?
Akoustis Technologies, Inc. stock price is $0.5581 today.
Is Akoustis Technologies, Inc. stock public?
Yes, Akoustis Technologies, Inc. is a publicly traded company.